BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31383643)

  • 1. Recurrent somatic
    Xiao W; Gupta GK; Yao J; Jang YJ; Xi L; Baik J; Sigler A; Kumar A; Moskowitz AJ; Arcila ME; Raffeld M; Pittaluga S; Dogan A; Jaffe ES
    Blood; 2019 Sep; 134(12):986-991. PubMed ID: 31383643
    [No Abstract]   [Full Text] [Related]  

  • 2. NK-cell enteropathy, a potential diagnostic pitfall of intestinal lymphoproliferative disease.
    Wang R; Kariappa S; Toon CW; Varikatt W
    Pathology; 2019 Apr; 51(3):338-340. PubMed ID: 30819538
    [No Abstract]   [Full Text] [Related]  

  • 3. NK cell enteropathy: a case report with 10 years of indolent clinical behaviour.
    Isom JA; Arroyo MR; Reddy D; Joshi-Guske P; Al-Quran SZ; Li Y; Allan RW
    Histopathology; 2018 Aug; 73(2):345-350. PubMed ID: 29474745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.
    Gasparini VR; Binatti A; Coppe A; Teramo A; Vicenzetto C; Calabretto G; BarilĂ  G; Barizza A; Giussani E; Facco M; Mustjoki S; Semenzato G; Zambello R; Bortoluzzi S
    Blood Cancer J; 2020 Apr; 10(4):42. PubMed ID: 32321919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review.
    Xia D; Morgan EA; Berger D; Pinkus GS; Ferry JA; Zukerberg LR
    Am J Clin Pathol; 2019 Jan; 151(1):75-85. PubMed ID: 30212873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Sim SH; Kim S; Kim TM; Jeon YK; Nam SJ; Ahn YO; Keam B; Park HH; Kim DW; Kim CW; Heo DS
    Am J Pathol; 2017 May; 187(5):980-986. PubMed ID: 28284718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.
    Koo GC; Tan SY; Tang T; Poon SL; Allen GE; Tan L; Chong SC; Ong WS; Tay K; Tao M; Quek R; Loong S; Yeoh KW; Yap SP; Lee KA; Lim LC; Tan D; Goh C; Cutcutache I; Yu W; Ng CC; Rajasegaran V; Heng HL; Gan A; Ong CK; Rozen S; Tan P; Teh BT; Lim ST
    Cancer Discov; 2012 Jul; 2(7):591-7. PubMed ID: 22705984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells.
    Kawakami T; Sekiguchi N; Kobayashi J; Yamane T; Nishina S; Sakai H; Hirabayashi Y; Nakazawa H; Ishida F
    Int J Hematol; 2019 May; 109(5):563-571. PubMed ID: 30859397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
    Perry AM; Warnke RA; Hu Q; Gaulard P; Copie-Bergman C; Alkan S; Wang HY; Cheng JX; Bacon CM; Delabie J; Ranheim E; Kucuk C; Hu X; Weisenburger DD; Jaffe ES; Chan WC
    Blood; 2013 Nov; 122(22):3599-606. PubMed ID: 24009234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets.
    Morice WG; Jevremovic D; Olteanu H; Roden A; Nowakowski G; Kroft S; Hanson CA; Kurtin PJ
    Leukemia; 2010 Apr; 24(4):881-4. PubMed ID: 20111066
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic lymphoproliferative disorder of NK cells with TNFAIP3 and DNMT3A mutations.
    Bulterys PL; Silva O
    Blood; 2021 Jun; 137(24):3460. PubMed ID: 34137843
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoproliferative Disorders of the Gastrointestinal Tract.
    Skinnider BF
    Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.
    Ng SB; Ohshima K; Selvarajan V; Huang G; Choo SN; Miyoshi H; Wang S; Chua HC; Yeoh AE; Quah TC; Koh LP; Tan PL; Chng WJ
    Orphanet J Rare Dis; 2014 Dec; 9():165. PubMed ID: 25475054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma.
    Guo Y; Arakawa F; Miyoshi H; Niino D; Kawano R; Ohshima K
    Pathol Int; 2014 Jun; 64(6):263-6. PubMed ID: 24965108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.
    Baer C; Kimura S; Rana MS; Kleist AB; Flerlage T; Feith DJ; Chockley P; Walter W; Meggendorfer M; Olson TL; Cheon H; Olson KC; Ratan A; Mueller ML; Foran JM; Janke LJ; Qu C; Porter SN; Pruett-Miller SM; Kalathur RC; Haferlach C; Kern W; Paietta E; Thomas PG; Babu MM; Loughran TP; Iacobucci I; Haferlach T; Mullighan CG
    Nat Genet; 2022 May; 54(5):637-648. PubMed ID: 35513723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications.
    de Martino M; Gigante M; Cormio L; Prattichizzo C; Cavalcanti E; Gigante M; Ariano V; Netti GS; Montemurno E; Mancini V; Battaglia M; Gesualdo L; Carrieri G; Ranieri E
    Urol Oncol; 2013 Aug; 31(6):930-7. PubMed ID: 21868263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
    Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
    Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations of JAK1 and JAK3 in acute leukemias and solid cancers.
    Jeong EG; Kim MS; Nam HK; Min CK; Lee S; Chung YJ; Yoo NJ; Lee SH
    Clin Cancer Res; 2008 Jun; 14(12):3716-21. PubMed ID: 18559588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell lymphoproliferative disorder complicated by a natural killer cell lymphoproliferative disorder of granular lymphocytes associated with T-cell gene rearrangement: case report and review of the literature.
    Dunphy CH; Martin AW; Dunphy FR
    Mod Pathol; 1995 Oct; 8(8):803-10. PubMed ID: 8552567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.